Carboxylate microspheres (CMs) are mainly used in industrial, biomedical and various household products. In this study, we assessed the cytotoxic effects of CMs on human MRC-5 lung fibroblasts by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Oxidative stress was determined by measurements of reactive oxygen species and antioxidant (superoxide dismutase and catalase) levels and proinflammatory cytokines quantified by enzyme-linked immunosorbent assay. Morphological changes were examined by light microscopy, confocal microscopy and transmission electron microscopy. The lung fibroblasts were exposed to increasing concentrations of CMs (0.1–1000 μmol/L) for 24 h. The results showed significant changes in cell morphology with induction of cytotoxicity and oxidative stress observed in 10–1000 μmol/L concentrations of CM-treated fibroblasts. Ultrastructural examination revealed the presence of CMs inside the cytoplasm of treated lung fibroblasts. CMs also induced elevated interleukin (IL)-1, IL-6, IL-8, IL-10 and tumor necrosis factor α levels at higher concentrations. We have demonstrated that CMs significantly reduce cell viability in a dose-dependant manner in lung fibroblasts at 0.1–1000 μmol/L doses. The findings suggest that high doses of CMs have the potential to induce cellular toxicity to the lung in vitro.
HäfeliU. Radioactive microspheres for medical applications. In: De CuyperM, BulteJWM, eds. Physics and Chemistry Basis of Biotechnology. Netherlands: Springer, 2001:213–48
2.
QuG, ZhuX, ZhangC, PingO. Modified chitosan derivative micelle system for natural anti-tumor product gambogic acid delivery. Drug Deliv2009;16:363–70
3.
FreemanI, KedemA, CohenS. The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials2008;29:3260–8
4.
MasahiroY, YoshimitsuU, Yoshizawahidekazu Y, YoshinobuK, ShojiN, TakashiA, YasuoH. Application of microsphere for cancer treatment. Pharm Tech Jpn2000;16:85–91
5.
TongW, WangL, DsouzaMJ. Evaluation of PLGA microspheres as delivery system for antitumor agent-camptothecin. Drug Dev Ind Pharm2003;29:745–56
6.
HeQ, AoQ, WangA, GongY, ZhaoN, ZhangX. In vitro cytotoxicity and protein drug release properties of chitosan/heparin microspheres. Tsinghua Sci. Technol2007;12:361–5
7.
YapFL, ZhangY. Assembly of polystyrene microspheres and its application in cell micropatterning. Biomaterials2007;28:2328–38
8.
AnghelI, HagaMJ, ReimusPW. Comparison of transport of carboxylate-modified latex microspheres and silica colloids in fractured and porous media: The case for microspheres as conservative colloid tracers. American Geophysical Union, Fall Meeting 2001, Abstract #H42C-0365. Seehttp://adsabs.harvard.edu/abs/2001AGUFM.H42C0365A
9.
ZalfenM, NizetD, JérômeC, JérômeR, FrankenneF, FoidartJM, MaquetV, LecomteF, HubertP, EvrardB. Controlled release of drugs from multi-component biomaterials. Acta Biomater2008;4:1788–96
10.
ChenX, OoiCP. Hydrolytic degradation and drug release properties of ganciclovir-loaded biodegradable microspheres. Acta Biomater2008;4:1046–56
11.
TanH, WuJ, LaoL, GaoC. Gelatin/chitosan/hyaluronan scaffold integrated with PLGA microspheres for cartilage tissue engineering. Acta Biomater2009;5:328–37
12.
DaiW, KawazoeN, LinX, DongJ, ChenG. The influence of structural design of PLGA/collagen hybrid scaffolds in cartilage tissue engineering. Biomaterials2010;31:2141–52
13.
BlakerJJ, KnowlesJC, RichardM. Day novel fabrication techniques to produce microspheres by thermally induced phase separation for tissue engineering and drug delivery. Acta Biomater2008;4:264–72
14.
HutmacherDW. Scaffolds in tissue engineering bone and cartilage. Biomaterials2000;21:2529–43
15.
ShiX, WangY, RenL, ZhaoN, GongY, WangD. Novel mesoporous silica-based antibiotic releasing scaffold for bone repair. Acta Biomaterialia2009;5:1697–707
16.
FanH, SunB, GuQ, Lafond-WalkerA, CaoS, BeckerLC. Oxygen radicals trigger activation of NF-kB and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am J Physiol Heart Circ Physiol2002;282:H1778–H86
17.
DriscollKE. TNF-alpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. Toxicol Lett2000;112-113:177–83
18.
JimenezLA, DrostEM, GilmourPS, RahmanI, AntonicelliF, RitchieH, MacNeeW, DonaldsonK. PM(10)-exposed macrophages stimulate a proinflammatory response in lung epithelial cells via TNF-alpha. Am J Physiol Lung Cell Mol Physiol2002;282:L237–L48
19.
BarrettEG, JohnstonC, OberdorsterG, FinkelsteinJN. Antioxidant treatment attenuates cytokine and chemokine levels in murine macrophages following silica exposure. Toxicol Appl Pharmacol1999;158:211–20
20.
FormanHJ, TorresM. Redox signaling in macrophages. Mol Aspects Med2001;2:189–16
21.
LiuQ, ShuhendlerA, ChengJ, RauthAM, O'BrienP, WuXY. Cytotoxicity and mechanism of action of a new ROS-generating microsphere formulation for circumventing multidrug resistance in breast cancer cells. Res Treat2010;121:323–33
22.
ParkEJ, YiJ, ChungKH, RyuDY, ChoiJ, ParkK. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol Lett2008;180:222–9
23.
NelsonS, MartinTR. Cytokines in pulmonary disease: infection and inflammation. In: GehrP, HeyderJ, eds. Lung Biology in Health and Disease. Vol. 141. New York: Marcel Dekker, 2000:437–72
24.
VeranthJM, KaserEG, VeranthMM, KochM, YostGS. Cytokine responses of human lung cells (BEAS-2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts. Part Fibre Toxicol2007;4:1–18
25.
ByrneJD, BaughJA. The significance of nanoparticles in particle-induced pulmonary fibrosis. McGill J Med2008;11:43–50
26.
WangL, CastranovaV, MishraA, ChenB, MercerRR, Schwegler-BerryD, RojanasakulY. Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part Fibre Toxicol2010;7:31
27.
KamataH, TasakaS, InoueK, MiyamotoK, NakanoY, ShinodaH, KimizukaY, FujiwaraH, IshiiM, HasegawaN, TakamiyaR, FujishimaS, TakanoH, IshizakaA. Carbon black nanoparticles enhance bleomycin-induced lung inflammatory and fibrotic changes in mice. Exp Biol Med2011;236:315–24
28.
WhiteB. Interstitial lung disease in scleroderma. Rheum Dis Clin North Am2003;29:371–90
McNearneyTA, ReveilleJD, FischbachM, FriedmanAW, LisseJR, GoelN, TanFK, ZhouX, AhnC, Feghali-BostwickCA, FritzlerM, ArnettFC, MayesMD. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum2007;57:318–26
31.
SteenVD, MedsgerTA. Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis2007;66:940–4
32.
CastelinoFV, VargaJ. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther2010;12:213
33.
KatsumotoTR, VioletteSM, SheppardD. Blocking TGFβ via inhibition of the αvβ6 integrin: a possible therapy for systemic sclerosis interstitial lung disease. Int J Rheum2011;2011:1–7
34.
Andersson-SjolandA, de AlbaCG, NihlbergK, BecerrilC, RamirezR, PardoA, Westergren-ThorssonG, SelmanM. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol2008;40:2129–40
35.
MoellerA, GilpinSE, AskK, CoxG, CookD, GauldieJ, MargettsPJ, FarkasL, DobranowskiJ, BoylanC, O'ByrnePM, StrieterRM, KolbM. Circulating fibrocytes are an indicator for poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med2009;179:588–94
36.
MathaiSK, GulatiM, PengX, RussellTR, ShawAC, RubinowitzAN, MurrayLA, SinerJM, Antin-OzerkisDE, MontgomeryRR, ReilkoffRAS, BucalaRJ, HerzogEL. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest2010;90:812–23
37.
KeeleyEC, MehradB, StrieterRM. The role of fibrocytes in fibrotic diseases of the lungs and heart. Fibrogenesis Tissue Repair2011;4:1–6
38.
DechsakulthornF, HayesA, BakandS, JoengL, WinderC. In vitro cytotoxicity assessment of selected nanoparticles using human skin fibroblasts. Proceedings of 6th World Congress on Alternatives and Animal Use in the Life Sciences. AATEX2008;14:397–400
39.
BakandS, HayesA, WinderC, KhalilC, MarkovicB. In vitro cytotoxicity testing of airborne formaldehyde collected in serum-free culture media. Toxicol Ind Health2005;21:147–54
40.
ElbekaiRH, El-KadiAO. The role of oxidative stress in the modulation of aryl hydrocarbon receptor-regulated genes by As3+, Cd2+, and Cr6+. Free Radic Biol Med2005;39:1499–511
41.
FotakisG, CemeliE, AndersonD, TimbrellJA. Cadmium chloride-induced DNA and lysosomal damage in a hepatoma cell line. Toxicol In Vitro2005;19:481–9
ShvedovaAA, KisinER, MercerR, MurrayAR, JohnsonVJ, PotapovichAI, TyurinaYY, GorelikO, ArepalliS, Schwegler-BerryD, HubbsAF, AntoniniJ, EvansDE, KuB, RamseyD, MaynardA, KaganVE, CastranovaV, PaulBP. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol2005;289:L698–708
44.
ClaiborneA. Catalase activity. In: GreenwaldRA, ed. Handbook of Methods for Oxygen Radical Research. Boca Raton, FL, USA: CRC press, 1985:283–4
45.
BeauchampCO, FridovichI. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem1971;44:276–87
46.
Abdel-FattahWI, JiangT, El-Tabie El-BassyouniG, LaurencinCT. Synthesis, characterization of chitosans and fabrication of sintered chitosan microsphere matrices for bone tissue engineering. Acta Biomater2007;3:503–14
47.
PorterDW, HubbsAF, BaronPA, MillecchialLL, WolfarthMG, BattelliLA, Schwegler-BerryDE, BeighleyCM, AndrewME, CastranovaV. Pulmonary toxicity of expancel microspheres in the rat. Toxicol Pathol2007;35:702–14
48.
CheungRY, RauthAM, RonaldsonPT, BendavanR, WuXY. In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin. Eur J Pharm Biopharm2006;62:321–31
49.
SivadasN, RourkeDO, TobinA, BuckleyV, RamtoolaZ, KellyJG, HickeyAJ, CryanS. A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. Int J Pharmaceutics2008;358:159–67
50.
InabaH, KawaiS, KatoT, NakagawaI, AmanoA. Association between epithelial cell death and invasion by microspheres conjugated to Porphyromonas gingivalis vesicles with different types of Fimbriae. Infect Immun2006;74:734–9
51.
YangW, PetersJI, WilliamsROIII. Inhaled nanoparticles: a current review. Int J Pharm2008;356:239–47
52.
LinW, HuangYW, ZhouXD, MaY. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol2006;217:252–9
53.
LongTC, TajubaJ, SamaP, SalehN, SwartzC, ParkerJ, HesterS, LowryGV, VeronesiB. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ Health Perspect2007;115:1631–7
54.
SimonHU, Hai-YehiaA, Levi-SchafferF. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis2000;5:415–8
55.
GutteridgeJM, HalliwellB. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann NY Acad Sci2000;899:136–47
56.
KyriakisJM, AvruchJ. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev2001;81:807–69
57.
BenharM, DalyotI, EngelbergD, LevitzkiA. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol2001;21:6913–26
58.
YoungIS, WoodsideJV. Antioxidants in health and disease. J Clin Pathol2001;54:176–86
59.
MacekováD, KováčG, HinštJ, IllekB, PerečkováJ, BaroškováZ, LíškaB. Lipid peroxidation and biochemical parameters in umbilical cord blood of well-adapted term newborns. Biologia2009;64:409–13
60.
TaoF, Gonzalez-FlechaB, KobzikL. Reactive oxygen species in pulmonary inflammation by ambient particulates. Free Radic Biol Med2003;35:327–40
61.
MemisogullariR, TaysiS, BakanE, CapogluI. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct2003;21:291–6
62.
ChouDS, LeeJJ, HsiaoG, HsiehCY, TsaiYJ, ChenTF, SheuJR. Baicalein induction of hydroxyl radical formation via 12-lipoxygenase in human platelets: an ESR study. J Agric Food Chem2007;55:649–55
63.
CullenRT, TranCL, BuchananD, DavisJMG, SearlA, JonesAD. Inhalation of poorly soluble particles 1. Differences in inflammatory response and clearance during exposure. Inhal Toxicol2000;12: 1089–111
64.
DriscollKE, CostaDL, HatchG, HendersonR, OberdorsterG, SalemH, SchlesingerRB. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci2000;55:24–35
65.
IshiiH, FujiiT, HoggJC, HayashiS, MukaeH, VincentR, van EedenSF. Contribution of IL-1 beta and TNF-alpha to the initiation of the peripheral lung response to atmospheric particulates (PM10). Am J Physiol Lung Cell Mol Physiol2004;287:L176–83
66.
FujiiT, HayashiS, HoggJC, VincentR, Van EedenSF. Particulate matter induces cytokine expression in human bronchial epithelial cells. Am J Respir Cell Mol Biol2001;25:265–71
67.
CarterJD, GhioAJ, SametJM, DevlinRB. Cytokine production by human airway epithelial cells after exposure to an air pollution particle is metal-dependent. Toxicol Appl Pharmacol1997;146:180–8
68.
IshiiH, HayashiS, HoggJC, FujiiT, GotoY, SakamotoN, MukaeH, VincentR, van EedenSF. Alveolar macrophage-epithelial cell interaction following exposure to atmospheric particles induces the release of mediators involved in monocyte mobilization and recruitment. Respir Res2005;6:1–12
69.
DonaldsonK, StoneV, BormPJ, JimenezLA, GilmourPS, SchinsRP, KnaapenAM, RahmanI, FauxSP, BrownDM, MacNeeW. Oxidative stress and calcium signaling in the adverse effects of environmental particles (PM10). Free Radic Biol Med2003;34:1369–82
70.
HwangYS, JeongM, ParkJS, KimMH, LeeDB, ShinBA, MukaidaN, EllisLM, KimHR, AhnBW, JungYD. Interleukin-1beta stimulates IL-8 expression through MAP kinase and ROS signaling in human gastric carcinoma cells. Oncogene2004;23:6603–11
71.
Pearl-YafeM, HalperinD, ScheuermanO, FabianI. The p38 pathway partially mediates caspase-3 activation induced by reactive oxygen species in Fanconi anemia C cells. Biochem Pharmacol2004;67:539–46
72.
KarinM, LinA. NF-kappa B at the crossroad of life and death. Nat Immunol2002;3:221–7
73.
ChandrasekarB, MelbyPC, SarauHM, RaveendranM, PerlaRP, Marelli-BergFM, DulinNO, SinghIS. Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway. J Biol Chem2003;278:4675–86
74.
SargentJL, MilanoA, BhattacharyyaS, ArgaJ, ConnollyMK, ChangHY, WhitfieldML. A TGF-beta responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity. J Invest Dermatol2010;130:694–705
75.
SimePJ, O'ReillyKM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol2001;99:308–19
76.
WillisBC, BorokZ. TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol2007;293:L525–L34
